| Item | Cat. No. | Type | Clone No |
| Anti-LINGO1 mAbs [Opicinumab Biosimilar] (MABL-5036) | MABL-5036 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-EPCAM/CD326 mAbs [Oportuzumab Biosimilar] (MABL-5037) | MABL-5037 | ELISA, FACS, Functional assay, in vivo binding | na, Kappa |
| Anti-PDL1/CD274 mAbs [Opucolimab Biosimilar] (MABL-5038) | MABL-5038 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-FOLR1;FOLR1 mAbs [Opugotamig Biosimilar] (MABL-5039) | MABL-5039 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-IL15 mAbs [Ordesekimab Biosimilar] (MABL-5040) | MABL-5040 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-FCGRT/FcRn mAbs [Orilanolimab Biosimilar] (MABL-5041) | MABL-5041 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-Rabies Virus Surface Glycoprotein 4 (gp4) Epitope 1 mAbs [Ormutivimab Biosimilar] (MABL-5042) | MABL-5042 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-OxLDL mAbs [Orticumab Biosimilar] (MABL-5043) | MABL-5043 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-CLDN18 mAbs [Osemitamab Biosimilar] (MABL-5044) | MABL-5044 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-F11 mAbs [Osocimab Biosimilar] (MABL-5045) | MABL-5045 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD3E mAbs [Otelixizumab Biosimilar] (MABL-5046) | MABL-5046 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-KDR/CD309/VEGFR2 mAbs [Olinvacimab Biosimilar] (MABL-5018) | MABL-5018 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-LGALS3/GAL3 mAbs [Oloctinebart Biosimilar] (MABL-5019) | MABL-5019 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL6 mAbs [Olokizumab Biosimilar] (MABL-5020) | MABL-5020 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IGHE mAbs [Omalizumab Biosimilar] (MABL-5021) | MABL-5021 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-B7H3/CD276 mAbs [Omburtamab Biosimilar] (MABL-5022) | MABL-5022 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CLDN18 mAbs [Omectatug Biosimilar] (MABL-5023) | MABL-5023 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-C5 mAbs [Omoprubart Biosimilar] (MABL-5024) | MABL-5024 | ELISA, FACS, Functional assay, in vivo binding | G2/G4, Kappa |
| Anti-Staphylococcus aureus Protein A mAbs [Omodenbamab Biosimilar] (MABL-5025) | MABL-5025 | ELISA, FACS, Functional assay, in vivo binding | G3, Kappa |
| Anti-IL13;IL4 mAbs [Ompekimig1 Biosimilar] (MABL-5026) | MABL-5026 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Kappa;Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
